Advertisement

Graft-Versus-Host Disease (GvHD): Cutaneous Manifestations

  • Peter HäusermannEmail author
  • Alan Tyndall
Chapter

Abstract

Graft-versus-host disease (GvHD) is the major immunological, mainly donor T-cell-derived, complication after allogeneic hematopoietic stem cell transplantation. GvHD occurs in about 50 % of patients and is directly related to the degree of mismatch between HLA proteins of host and donor. Fast-proliferating organs such as skin, liver, and gastrointestinal tract are predominantly involved. Cutaneous manifestations are broad and mucous membranes and adnexal structures can be affected as well. Today, acute GvHD is divided into classic, persistent, recurrent, or late-onset disease, and chronic GvHD is categorized as classical or overlap syndrome.

Keywords

Atopic Dermatitis Systemic Sclerosis Acute GvHD Allogeneic Hematopoietic Stem Cell Transplantation Chronic GvHD 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813.PubMedCrossRefGoogle Scholar
  2. 2.
    Ferrara JLM, et al. Graft-versus-host disease. Lancet. 2009;373:1550.PubMedCrossRefGoogle Scholar
  3. 3.
    Shlomchik WD. Graft-versus-host disease. Nature Rev Immunol. 2007;7:340.CrossRefGoogle Scholar
  4. 4.
    Wagner JL, Murphy GF. Pathology and pathogenesis of cutaneous graft-versus-host disease. In: Ferrara JLM, Cooke KR, Deeg HJ, editors. Graft-vs-host disease. 3rd ed. New York: Marcel Dekker; 2005. p. 229–57.Google Scholar
  5. 5.
    Häusermann P, et al. Cutaneous graft-versus-host disease: a guide for the dermatologist. Dermatology. 2008;216:287.PubMedCrossRefGoogle Scholar
  6. 6.
    Filipovitch AH et al. 14. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report, Biol Blood Marrow Transplant. 2005;11:945.Google Scholar
  7. 7.
    Schaffer JV. The changing face of graft-versus-host disease. Semin Cutan Med Surg. 2006;25:190.PubMedCrossRefGoogle Scholar
  8. 8.
    Mays SR, et al. Approach to the morbilliform eruption in the hematopoietic transplant patient. Semin Cutan Med Surg. 2007;26:155.PubMedCrossRefGoogle Scholar
  9. 9.
    Shulman HM, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in chronic Graft-versus-Host Disease: II. Pathology working Group Report. Biol Blood Marrow Transplant. 2006;12:31.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2014

Authors and Affiliations

  1. 1.Department of DermatologyUniversity Hospital BaselBaselSwitzerland
  2. 2.Department of Rheumatology, Felix Platter SpitalUniversity Hospital BaselBaselSwitzerland

Personalised recommendations